Welcome to the first series of virtual symposia organized by the Finnish Brain Tumor Research Association on the 28th of October 2020.
Please note the updated time: 3:50pm Helsinki/10am Boston
We are inaugurating these meetings with the exceptional participation of pioneering investigators of the brain tumor heterogeneity and evolution. Single-cell RNA sequencing technologies are one of the most recent scientific and medical breakthrough. By allowing to determine the genetic profile of individual cells from an heterogenous tumor biopsy, this technology allowed very significant progress in the understanding of the brain tumor biology and personalized diagnosis.
We are honoured to host Prof. Mario Suvà (Massachusetts General Hospital, Broad Institute of Harvard and MIT, USA) for a keynote lecture on his groudbreaking discovery recently published in Cell (https://doi.org/10.1016/j.cell.2019.06.024), revealing that glioblastoma tumour cells exhibit different phenotypic states with consequences on the tumor plasticity and progression. He will also share with us ongoing investigations on other types of brain cancers, including paediatric brain tumours and medulloblastoma.
Dr. Toshiro Hara is a main contributor in the discovery of the phenotypic states that brain tumor cells exhibit. He will comment on the story leading to this discovery and the perspectives offered by the single cell transcriptomics technology in addition to presenting us very recent data on the glioblastoma-immune cell interactions at the single-cell resolution.
Mrs. Kaiyang Zhang will share with us her experience with the computational analysis of large datasets of patient tumor cells. During this live interactive session, we will perform the analysis, on screen, while commenting on the methodology.
Save the date! We are looking forward to meeting you on October.
The event is free-of-charge for FiBTRA members.